Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Supplement Cycling

On/Off Schedules, Tolerance, and Why People Cycle Adaptogens

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not FDA evaluated

Reference only. Not medical advice.

What can go wrong

Ashwagandha has case reports of hepatotoxicity and can affect thyroid hormone and interact with sedatives, immunosuppressants, and thyroid medication; pausing limits cumulative exposure. Tongkat ali quality and contamination (including heavy metals in some products) vary widely. Cycling does not make a contaminated product safe, sourcing matters more than the schedule.

This is something to take to a clinician. The Atlas can tell you what is known about supplement cycling in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

The practice of taking a supplement for a defined block (commonly 8-12 weeks) then pausing (2-4 weeks), most often applied to ashwagandha and tongkat ali. Reasons cited are perceived tolerance, concern about long-term endocrine or organ effects, and cost. Tolerance to these herbs' testosterone effects has not been well demonstrated, so cycling is a precautionary norm more than an evidence-based requirement.

Cycling is mostly precaution, not proven pharmacology.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Limiting continuous adaptogen exposure
  • Resetting perceived tolerance
  • Reducing cost of standardized extracts

How it is supposed to work

The cycling rationale borrows from drug pharmacology: receptors downregulate with continuous agonism, so a washout might restore responsiveness. For ashwagandha (a cortisol-modulating adaptogen) and tongkat ali (claimed SHBG reduction), tolerance to the testosterone effect specifically has limited direct evidence. Most positive trials ran fixed 8-12 week courses and did not test whether benefit fades or whether a break restores it.

The off-phase is the safety lever, not the efficacy lever

The strongest argument for cycling is reducing cumulative exposure to compounds whose long-term safety in continuous use is not characterized, not a documented tolerance curve. Framed honestly, cycling is risk hygiene for under-studied botanicals.

What has to be monitored

The bloodwork this needs, and the reason it belongs with a clinician rather than a website.

  • Liver function tests if using ashwagandha long-term or stacking hepatically-processed herbs
  • Thyroid panel if symptomatic on ashwagandha

What people get wrong

  • Often saidYou must cycle or the supplement stops working

    ActuallyTolerance to the testosterone effect of these herbs is not well established. Cycling is mostly a precaution about long-term exposure.

  • Often saidCycling prevents all harm

    ActuallyAn off-phase reduces cumulative dose but does not address contamination, underdosing, or drug interactions during the on-phase.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Typical on-phase
8-12 weeks
Typical off-phase
2-4 weeks
Most cycled agents
Ashwagandha, tongkat ali

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Supplement Cycling. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • KSM-66 ashwagandha RCT, healthy men2019

    600 mg/day for 8 weeks raised testosterone ~15% vs ~3% placebo; trial ended at 8 weeks, so durability beyond that was not assessed